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Abstract
Background: The incidence of superior vena cava syndrome within the United States is roughly 15,000 cases per
year. Superior vena cava syndrome is a potentially life-threatening medical condition; however, superior vena cava
syndrome is not fatal in the majority of cases. Superior vena cava syndrome encompasses a collection of signs and
symptoms resulting from obstruction of the superior vena cava, including swelling of the upper body of the head,
neck, arms, and/or breast. It is also associated with cyanosis, plethora, and distended subcutaneous vessels. Lung
cancer, including both non-small cell lung cancer and small cell lung cancer, is the most common extrinsic cause of
superior vena cava syndrome. Intrinsic disruption of superior vena cava flow can also precipitate superior vena cava
syndrome. This case report describes an unusual presentation and potential etiology of superior vena cava
syndrome.
Case presentation: Our patient was a 51-year-old black woman with locally advanced, stage IIIB non-small cell
lung cancer who had no clinical symptoms of superior vena cava syndrome at the time of diagnosis. However, she
did have radiographic evidence of superior vena cava stenosis caused by extrinsic compression from her large right
hilar primary tumor. She was treated with definitive chemoradiation, receiving 60 Gy of external beam radiation
therapy given concurrently with chemotherapy. Three months after completion of radiotherapy, she developed
signs of superior vena cava syndrome, including breast and supraclavicular swelling. She had a chest computed
tomography scan showing over 50% reduction in the size of a right hilar mass; however, she had continued
radiographic stenosis of the superior vena cava. The distribution of stenosis appeared to be inferior to the caudal
extent of pretreatment tumor volume. She had no other radiographic indications for superior vena cava syndrome.
Conclusions: Generally, superior vena cava syndrome is the result of extrinsic compression of the superior vena
cava by tumor. Our patient’s case represents the development of superior vena cava syndrome after an excellent
response of tumor with near-complete tumor response. We suspect chemoradiation therapy as a potential etiology
for the precipitation of the superior vena cava syndrome, which is currently not well reported in the medical
literature.
Keywords: Radiation-induced SVC syndrome, SVC syndrome
* Correspondence: hintonja@iu.edu
1Department of Radiation Oncology, Indiana University School of Medicine,
535 Barnhill Drive, Cancer Care Pavilion 041, Indianapolis, IN 46202-5289, USA
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hinton et al. Journal of Medical Case Reports  (2018) 12:301 
https://doi.org/10.1186/s13256-018-1843-4
Background
Superior vena cava (SVC) syndrome encompasses a col-
lection of signs and symptoms resulting from obstruc-
tion of the SVC, including swelling of the upper body of
the head, neck, arms, and/or breast. It is also associated
with cyanosis, plethora, and distended subcutaneous ves-
sels. The edema that develops may cause functional defi-
cits of the larynx or pharynx, contributing to cough,
hoarseness, dyspnea, and dysphagia.
SVC syndrome historically was considered an onco-
logic emergency and was one of only a handful of emer-
gent indications for palliative radiation therapy. The
incidence of SVC syndrome within the United States is
roughly 15,000 cases per year [1]. SVC syndrome is a
potentially life-threatening medical condition; however,
it is not fatal in the majority of cases [2]. A retrospective
literature review including 1986 patients with SVC syn-
drome between 1934 and 1984 reported only 1 death
that could be directly attributed to SVC obstruction [2].
SVC syndrome can be the result of either extrinsic
compression or intrinsic disruption of venous blood
flow. The pace of the onset of venous restriction is the
main driver behind the development of SVC syndrome.
Slowly developing SVC lesions can result in the develop-
ment of collateral circulation through the inferior vena
cava and the azygous vein that can mitigate or even
eliminate the development of SVC syndrome.
Lung cancer, including both non-small cell lung cancer
(NSCLC) and small cell lung cancer, is the most common
extrinsic cause of SVC syndrome [1]. Two to four percent
of all patients with lung cancer develop SVC syndrome at
some point during their disease course [3–5]. SVC syn-
drome is more common in small cell lung cancer, occurring
in approximately 10% of cases [6]. Other extrinsic etiologies
of SVC syndrome include lymphoma and metastatic dis-
ease, as well as nonmalignant causes, including aortic
aneurysm [7, 8]. Intrinsic causes include both superior and
inferior vena cava stenosis, thrombosis, and use of intraven-
ous catheters. Radiation has only briefly been described in
the literature as an etiology of SVC syndrome [9–11].
Generally, SVC syndrome is the result of extrinsic
compression of the SVC by tumor. Our patient’s case
represents the development of SVC syndrome after an
excellent near-complete tumor response. We suspect
that chemoradiotherapy is a potential etiology for the
precipitation of the SVC syndrome, which is currently
not well reported in the medical literature. This case re-
port adds to the medical literature by describing radi-
ation as a potential cause of SVC syndrome.
Case presentation
A 51-year-old black woman with an 18-pack-year smok-
ing history presented to our institution with a 3-month
history of a progressively productive cough unresponsive
to antibiotics. In addition, she had dyspnea on exertion
and a 25-pound weight loss. Her past medical history in-
cluded a duodenal ulcer resulting in a perforation
which required exploratory laparotomy 2 years prior to
presentation. Other history included subarachnoid
hemorrhage requiring craniotomy with hematoma
evacuation roughly 20 years prior to presentation, as
well as hypertension. Her family history included her
mother being diagnosed with ovarian cancer at the age
of 54. The patient is married and worked full-time at the
front desk for the past 30 years for a shipping company.
She reported alcohol intake of two drinks per occasion
twice weekly. She denied the use of any recreational
drugs. She denied any environmental exposures. Medica-
tions that the patient was receiving at the time of diag-
nosis included amlodipine and albuterol.
The patient underwent computed tomography (CT) of
the chest, which revealed a 5.3 × 6-cm right hilar mass
that was occluding the right upper lobe bronchus with
narrowing of the SVC. The SVC remained radiographic-
ally patent (Fig. 1a, b). The patient’s vital signs included
afebrile temperature of 37.0 °C, cardiac pulse of 100
beats per minute, and oxygen saturation of 96% on room
air. Her physical examination at that time was without
any clinical signs of venous congestion. She had no facial
plethora and had flat neck veins and no signs of jugular
vein distention. She had decreased breath sounds in the
right upper and middle lung fields. The skin of the neck
and breast was without any pitting or edema. Neuro-
logically, the patient was fully functional with cranial
nerves II–XII intact and 5/5 strength in the upper and
lower extremities bilaterally. All laboratory test results,
including complete blood count and comprehensive
metabolic panel, were within normal limits.
Two weeks after the patient’s initial presentation, she
was found to have bilateral distended venous jugular
veins, with no facial, neck, or breast fullness, which was
self-limiting and resolving prior to chemoradiation. She
eventually underwent an endobronchial ultrasound with
fine-needle aspiration of the right hilar mass along with
the contralateral mediastinal station 4L lymph node
demonstrating poorly differentiated NSCLC adenocar-
cinoma in both sites. She then underwent brain mag-
netic resonance imaging (MRI) and positron emission
tomography (PET)/CT (Fig. 2a), which revealed no evi-
dence of metastatic disease. She was diagnosed with
T2bN3M0 stage IIIB lung adenocarcinoma according to
American Joint Committee on Cancer 8th edition sta-
ging guidelines.
The patient proceeded with expedited radiation plan-
ning and treatment, given her radiographic evidence of
extrinsic SVC narrowing and physical examination find-
ings of mild and self-limiting jugular venous distention.
She received a definitive radiation dose of 60 Gy in 30
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fractions concurrent with chemotherapy (cisplatin and
etoposide). The patient was simulated in the supine pos-
ition in a whole-body Vac-Lok ™ (CIVCO Radiotherapy,
Orange City, IA, USA) with arms above her head. A
four-dimensional (4D) CT simulation was performed
using a Philips Ingenuity CT simulation scanner (Philips,
Cleveland, OH, USA) to acquire images for treatment
planning and assessment of internal target motion.
Treatment planning was performed using an Eclipse®
treatment planning system (Varian Medical Systems, Pao
Alto, CA, USA), and treatment was delivered using a
TrueBeam® radiotherapy system (Varian Medical Systems)
with two volumetric modulated arc therapy arcs using
6-MV photons. Gross tumor volume (GTV) was con-
toured on 4D CT images in different phases of the re-
spiratory cycle. An internal target volume was created by
Fig. 1 Superior vena cava (SVC) is patent pretreatment, as seen by contrast below the tumor in (a) and (b). The inferior portion of the SVC is
narrowed 3 and 6 months posttreatment, as seen in (c) and (d), respectively
Fig. 2 Positron emission tomography/computed tomography shows large right hilar mass pretreatment (a) and 3 months posttreatment (b)
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the summation of GTV volumes of the different respira-
tory phases. A 5-mm expansion was used to create the
clinical target volume and planning target volume (PTV),
respectively. Ninety-five percent of the PTV received at
least 57 Gy or 95% of the prescribed dose (Fig. 3). Cycle 1
of cisplatin (50 mg/m2 on days 1, 8, 29, and 36) plus eto-
poside (50 mg/m2 daily on days 1 to 5 and days 29 to 33)
started 2 weeks after initiation of radiation therapy. One
additional cycle was given after completion of radiation
for a total of two cycles of chemotherapy received. The pa-
tient did experience some breast swelling and pain that
was seen with day 10 of chemotherapy. The event was
suspected to be a consequence of the excess intravenous
fluids (3 L) coadministered with each infusion of cisplatin.
This event was in the setting of the previous stenosis of
the SVC resulting from extrinsic compression from the
patient’s large right hilar mass. This swelling resolved
within 1 week without intervention. The patient also de-
veloped esophagitis requiring temporary gastric tube
placement necessitating a 5-day hospitalization.
The patient returned to the radiation oncology depart-
ment for a 3-month posttreatment follow-up visit, for
which imaging was ordered. The patient reported that for
the past 2 weeks she had developed swelling and pain in
her right breast and right supraclavicular region, which
were new for her. She also complained of worsening
dyspnea on exertion, a 16-pound weight gain over the past
3 months, and intermittent headaches. She denied any fa-
cial fullness, orthopnea, or dysphagia. Examination revealed
that her vital signs were within normal limits; however, she
had obvious compressible swelling of the right supra-
clavicular region and fullness within the right breast.
Chest CT performed 2 days prior to the follow-up visit
revealed a remarkable reduction in size by approxi-
mately 50% of the treated right hilar mass (Fig. 1c).
However, the SVC was significantly narrowed to com-
pletely occluded radiographically, despite being
narrowed but patent before treatment. The patient was
sent to the emergency department for further evalu-
ation and management. Interventional radiology was
consulted, and it was concluded that the patient’s SVC syn-
drome was likely chronic based on the presence of signifi-
cant collaterals. No acute intervention was recommended,
and she was discharged to home uneventfully.
The patient did have initial radiographic evidence of
stenosis of the SVC; however, her initial stenosis did not
produce SVC syndrome. The patient did respond very
well to treatment, because she had marked reduction of
the tumor volume and decrease in the extent of extrinsic
compression on the SVC. It was peculiar that she devel-
oped SVC syndrome despite her significant treatment
response.
Fig. 3 Radiation plan showing 95% isodose coverage (57 Gy). The entire superior vena cava (SVC) is within the planning target volume or high-
dose region of radiotherapy. (a) Axial, (b) coronal, and (c) sagittal planning computed tomographic scans. d Dose-volume histogram analysis of
SVC (magenta)
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We also contemplated intrinsic etiologies for SVC syn-
drome, including thrombus formation, but this consider-
ation was not confirmed on radiographs. Interventional
radiology was consulted and had reviewed her films and
did not think thrombus was a likely scenario. There was
a concern for recurrent or persistent microscopic disease
within the region of the SVC, but there was no fludeoxyglu-
cose avidity in the region on posttreatment PET (Fig. 2b).
The development of an adequate collateral circulation sys-
tem did indicate the chronicity of venous congestion. The
differential diagnosis also included the possibility that the
continued stenosis of the SVC was a direct effect of treat-
ment (chemoradiation) because the SVC resided within the
PTV receiving the full radiation dose. The SVC was con-
toured, and dosimetric parameters were as follows: Mini-
mum dose to SVC was 59.74 Gy with maximum dose to
SVC 62.36 Gy, and 95% of the SVC received at least
60.35 Gy (Fig. 3).
The patient was presented at the multidisciplinary
thoracic oncology tumor board, and observation was
recommended on the basis of absence of tumor progres-
sion and presence of an adequate collateral venous sys-
tem. Her supraclavicular and breast swelling was
self-limited, resolving within 2 weeks after her presenta-
tion. Six months after completion of radiation therapy,
she underwent PET/CT indicating recurrent thoracic
disease and had a fine-needle aspiration biopsy confirm-
ing metastatic, poorly differentiated adenocarcinoma in
a station 4R lymph node. She was placed on the PD-1
(programmed cell death protein 1) inhibitor nivolumab.
Brain MRI was performed for workup, revealing two
ring-enhancing lesions in the left frontal and right cere-
bellum, the largest of which was 2.2 × 1.8-cm in the left
frontal lobe. Gamma Knife® (Elekta, Stockholm, Sweden)
stereotactic radiosurgery was performed on the two le-
sions. One year after completion of definitive thoracic
radiotherapy, the patient was found to have a new meta-
static left parieto-occipital brain lesion that was being
worked up at the time of this report. She has not had re-
development of SVC syndrome.
Discussion
SVC syndrome generally is caused by extrinsic compres-
sion of the flexible SVC by tumor. The unique character-
istic of this case is that the SVC syndrome developed
with decreasing extrinsic compression. Radiation is sus-
pected as the direct cause of SVC syndrome in our pa-
tient, which adds to the paucity of data portraying
radiation as an etiology of SVC syndrome.
Radiation-induced injury to blood vessels was discov-
ered by pathologists soon after the invention of x-rays
[12]. However, radiation damage to veins has not been
evaluated as well as radiation damage to the arterial sys-
tem [13, 14]. Radiation-related pathologic changes within
veins include intimal proliferation and formation of fi-
brous plaques [12]. Several case reports describe
radiation-induced SVC syndrome. These case reports all
describe radiation-induced fibrosis and SVC syndrome
that developed years after completion of radiation therapy.
Lee et al. described a case a 59-year-old man who received
adjuvant radiation therapy for primary germinal cell
tumor of the mediastinum [6]. The patient underwent re-
section of a mediastinal mass followed by radiation ther-
apy to a total dose of 32 Gy given in 2-Gy fractions. His
treatment was performed 20 years prior to the develop-
ment of SVC syndrome, which manifested as a headache
with facial and neck edema. There was radiographic evi-
dence of complete occlusion of the SVC. Venous decom-
pression was achieved by left internal jugular anastomosis
to the right atrium. During surgical resection, the prox-
imal portion of SVC, right brachiocephalic vein, and in-
nominate vein appeared to be fibrotic, with biopsy
confirming fibrosis without recurrence of the tumor.
Mehta et al. described a patient who received definitive
radiotherapy in Cuba for Hodgkin’s lymphoma 50 years
prior to her presentation of SVC syndrome [9]. No other
cause for SVC was identified, and the radiation dose is un-
known. Van Putten et al. also reported cases of two pa-
tients with suspected radiation-induced SVC syndrome
[11]. The first patient was a 47-year-old man who received
60 Gy to mediastinal paratracheal nodes adjacent to the
SVC in the treatment of recurrent lung cancer 2 years
after pneumonectomy. Five years after radiation therapy,
the patient developed SVC syndrome manifested as facial
and neck swelling without CT or PET evidence of recur-
rence of the mediastinal mass. The SVC syndrome re-
solved with stent placement. The second patient was a
36-year-old man who developed solitary metastatic disease
to a right-sided cervical lymph node receiving 50 Gy in
2-Gy fractions to the bilateral neck in the cervical and
supraclavicular regions along with a 20-Gy boost to the
gross tumor with electron beams. Seven years after radio-
therapy, he developed right arm swelling. Venography
confirmed no flow through the brachiocephalic vein, and
the patient ultimately underwent mediastinoscopy and
sternotomy, confirming fibrosis without any evidence of
malignancy. PET also confirmed no evidence of recurrent
disease.
Conclusions
Our patient’s case differs from the previously mentioned
cases in that the formation of the SVC syndrome oc-
curred just 3 months after the completion of radiother-
apy, much earlier than previously reported. Our patient
did have radiographic, but not clinical, evidence of SVC
stenosis at the time of diagnosis, which was due to her
very large hilar mass with extrinsic compression of the
SVC. The unique part of our patient’s case is the fact
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that development of SVC syndrome coincided with re-
markable reduction in the size of her tumor and pre-
sumed lessening of the extrinsic compression. The
majority of the patient’s SVC was within the full-dose re-
gion of radiotherapy. It is possible that the development
of the SVC syndrome was a chemoradiation-related
event, but it is not uncommon for the SVC to get the
full dose of radiation in the treatment of thoracic malig-
nancies. In addition, the location of the SVC stenosis
changed when we compared the pre- and the posttreat-
ment radiologic scans. It appears that up to an 8-cm seg-
ment of SVC was narrowed after treatment, some of
which was below the initial area of compression but
within the high-dose radiation area. Furthermore, it was
considered that the SVC syndrome could be related to
microscopic extension of the tumor beyond what could
be identified on imaging studies. The possibility of
microscopic tumor extension more caudally in the SVC
(i.e., the region that was found to be stenotic at
follow-up) should be considered, even though there was
no macroscopic tumor in that area seen on CT scans. In
conclusion, we believe that our patient’s case displays a
variety of potential etiologies for SVC syndrome, includ-
ing radiation therapy.
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